Cargando…

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease

Buruli ulcer, caused by infection with Mycobacterium ulcerans, is a necrotizing disease of the skin and subcutaneous tissue, which is most prevalent in rural regions of West African countries. The majority of clinical presentations seen in patients are ulcers on limbs that can be treated by eight we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolz, Miriam, Kerber, Sarah, Zimmer, Gert, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537091/ https://www.ncbi.nlm.nih.gov/pubmed/26275222 http://dx.doi.org/10.1371/journal.pntd.0004011

Ejemplares similares

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer
por: Bolz, Miriam, et al.
Publicado: (2016)

Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mapé River
por: Vandelannoote, Koen, et al.
Publicado: (2020)

Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice
por: Bieri, Raphael, et al.
Publicado: (2016)

Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2022)

Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens
por: Bratschi, Martin W, et al.
Publicado: (2014)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates
por: Bénard, Angèle, et al.
Publicado: (2016)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
por: Bolz, Miriam, et al.
Publicado: (2015)

A Sero-epidemiological Approach to Explore Transmission of Mycobacterium ulcerans
por: Ampah, Kobina Assan, et al.
Publicado: (2016)

Differential Gene Repertoire in Mycobacterium ulcerans Identifies Candidate Genes for Patho-Adaptation
por: Käser, Michael, et al.
Publicado: (2008)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Ongoing Genome Reduction in Mycobacterium ulcerans
por: Rondini, Simona, et al.
Publicado: (2007)

Evaluating decontamination protocols for the isolation of Mycobacterium ulcerans from swabs
por: Owusu, Enid, et al.
Publicado: (2017)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Genomic Diversity and Evolution of Mycobacterium ulcerans Revealed by Next-Generation Sequencing
por: Qi, Weihong, et al.
Publicado: (2009)

Spatiotemporal Co-existence of Two Mycobacterium ulcerans Clonal Complexes in the Offin River Valley of Ghana
por: Lamelas, Araceli, et al.
Publicado: (2016)

Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus
por: Halbherr, Stefan J., et al.
Publicado: (2013)

Late Onset of the Serological Response against the 18 kDa Small Heat Shock Protein of Mycobacterium ulcerans in Children
por: Röltgen, Katharina, et al.
Publicado: (2014)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans
por: Scherr, Nicole, et al.
Publicado: (2013)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans
por: Käser, Michael, et al.
Publicado: (2007)

Development of a Temperature-Switch PCR-Based SNP Typing Method for Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2012)

Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies
por: Ricklin, Meret E., et al.
Publicado: (2016)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis
por: Zimmer, Gert
Publicado: (2010)

Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs
por: Ricklin, Meret E., et al.
Publicado: (2017)

The cell surface protein MUL_3720 confers binding of the skin pathogen Mycobacterium ulcerans to sulfated glycans and keratin
por: Day, Christopher J., et al.
Publicado: (2021)

Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting
por: Tanghe, Audrey, et al.
Publicado: (2008)

Sero-Epidemiology as a Tool to Screen Populations for Exposure to Mycobacterium ulcerans
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2012)

Serological Evaluation of Mycobacterium ulcerans Antigens Identified by Comparative Genomics
por: Pidot, Sacha J., et al.
Publicado: (2010)

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
por: Bibert, Stéphanie, et al.
Publicado: (2017)

Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans
por: Dangy, Jean-Pierre, et al.
Publicado: (2016)

In-vitro Activity of Avermectins against Mycobacterium ulcerans
por: Omansen, Till F., et al.
Publicado: (2015)

Mycobacterium ulcerans Disease, Peru
por: Guerra, Humberto, et al.
Publicado: (2008)

The immunology of other mycobacteria: M. ulcerans, M. leprae
por: Röltgen, Katharina, et al.
Publicado: (2020)

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus
por: Kim, Young Chan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2d4j21klqgpd59j5evp41nsr23